Swiss National Bank’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-52,000
| Closed | -$1.52M | – | 2569 |
|
|
2017
Q3 | $1.52M | Buy |
52,000
+2,200
| +4% | +$61.6K | ﹤0.01% | 1810 |
|
|
2017
Q2 | $1.31M | Hold |
49,800
| – | – | ﹤0.01% | 1867 |
|
|
2017
Q1 | $1.17M | Hold |
49,800
| – | – | ﹤0.01% | 1926 |
|
|
2016
Q4 | $1.25M | Hold |
49,800
| – | – | ﹤0.01% | 1874 |
|
|
2016
Q3 | $1.4M | Sell |
49,800
-1,500
| -3% | -$38.5K | ﹤0.01% | 1745 |
|
|
2016
Q2 | $1.26M | Buy |
51,300
+1,100
| +2% | +$27.3K | ﹤0.01% | 1824 |
|
|
2016
Q1 | $1.07M | Buy |
50,200
+12,500
| +33% | +$333K | ﹤0.01% | 1857 |
|
|
2015
Q4 | $1.32M | Hold |
37,700
| – | – | ﹤0.01% | 1614 |
|
|
2015
Q3 | $1.07M | Buy |
37,700
+5,300
| +16% | +$178K | ﹤0.01% | 1741 |
|
|
2015
Q2 | $1.08M | Sell |
32,400
-1,600
| -5% | -$49.1K | ﹤0.01% | 1749 |
|
|
2015
Q1 | $958K | Buy |
34,000
+3,200
| +10% | +$79.5K | ﹤0.01% | 1788 |
|
|
2014
Q4 | $638K | Hold |
30,800
| – | – | ﹤0.01% | 2025 |
|
|
2014
Q3 | $752K | Hold |
30,800
| – | – | ﹤0.01% | 1829 |
|
|
2014
Q2 | $881K | Hold |
30,800
| – | – | ﹤0.01% | 1796 |
|
|
2014
Q1 | $862K | Buy |
30,800
+7,200
| +31% | +$177K | ﹤0.01% | 1797 |
|
|
2013
Q4 | $507K | Hold |
23,600
| – | – | ﹤0.01% | 1978 |
|
|
2013
Q3 | $313K | Sell |
23,600
-1,600
| -6% | -$21.6K | ﹤0.01% | 2195 |
|
|
2013
Q2 | $349K | Buy |
+25,200
| New | +$357K | ﹤0.01% | 2139 |
|
Swiss National Bank's PMC Position: Q4 2017 in Review
Swiss National Bank sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 52,000 shares — an estimated $1.52M sold.
Swiss National Bank first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $1.52M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Swiss National Bank reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Swiss National Bank sold 52,000 PharMerica Corporation shares in Q4 2017, an estimated $1.52M.
- Swiss National Bank first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Swiss National Bank's PharMerica Corporation position peaked at $1.52M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.